Front Page

Previous Story

Next Story

NIH Record


Roy Hertz Is Mourned

Dr. Roy Hertz, former NCI researcher and NICHD scientific director, died Oct. 28 at age 93. He came to NIH in 1941. He became chairman of the endocrinology section at the National Cancer Institute before becoming NICHD's scientific director and then chief of NICHD's Reproductive Research Branch.

In 1956, he developed the anticancer drug methotrexate, the first successful treatment for choriocarcinoma, a cancer of the placenta. This was the first effective chemotherapy for a solid tumor.

Dr. Roy Hertz
In 1972, he received the Albert Lasker Award for Clinical Research for this achievement. Hertz developed two synthetic forms of the hormone progestin, which later provided the basis for the development of oral contraceptives. He also developed drugs useful for the treatment of Cushing's disease, a disorder of the adrenal glands.

There will be a memorial program for Hertz on Saturday, Dec. 7 at 3 p.m. in the Clinical Center chapel. A reception will follow. For more information call Hertz's daughter, Margaret Brodkin, at (415) 863-2710 or email her at All friends and colleagues of Hertz's are welcome to attend.

Up to Top